Medicinal Chemistry

Eurofins teams of medicinal chemists can deliver compounds ready for pre-clinical candidate development and the clinic. Indeed, their track record of success is impressive, having put over 40 compounds into clinical trials.
 
Our experts offer flexibility in starting points, having experience starting from HTS screens, virtual screens, or the patent literature, to begin the iterative process of Hit-to-Lead and lead optimization. Since each project requires the final novel and patentable candidate molecule to have a specific balance of potency, selectivity, ADME and PK properties, our medicinal chemists must balance these properties in their data-driven design approach, as well as work with our synthetic chemistry group to ensure synthetic feasibility. The synergy between teams and their geographical locales ensures efficient optimization cycle times.